Biotechnology
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

$1.6M

Market Cap • 11/18/2024

2022

(2 years)
Founded

2023

(1 year ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Washington, D.C

Headquarters • Washington